Finance

Beta
Lists
INDGN:NSE
Indegene Ltd
₹509.15
-0.34%
(-1.75) 1D
Jul 20, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for INDGN...
Open
₹507.10
High
₹512.90
Low
₹504.40
Mkt. cap
122.67B
Avg. vol.
205.46K
Volume
91.32K
Dividend
0.44%
Quarterly dividend
₹0.56
Ex-dividend date
Jul 31, 2026
P/E ratio
30.45
52-wk high
₹596.80
52-wk low
₹414.00
EPS
₹16.72
No. of employees
5K
Open
₹507.10
High
₹512.90
Low
₹504.40
Mkt. cap
122.67B
Avg. vol.
205.46K
Volume
91.32K
Dividend
0.44%
Quarterly dividend
₹0.56
Ex-dividend date
Jul 31, 2026
P/E ratio
30.45
52-wk high
₹596.80
52-wk low
₹414.00
EPS
₹16.72
No. of employees
5K
News stories
From sources across the web
Profile
Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises. Based in Bangalore, the company provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics. Wikipedia
About Indegene Ltd
CEOManish Gupta
Employees4.69K
Founded1998
Headquarters-
SectorHealth care
Websiteindegene.com
Next call in 10 days
Thu, Jul 30, 11:30 PM
Fiscal period
Q1 2027
EPS / Est. (INR)
- / ₹4.62
Revenue / Est. (INR)
- / 10.56B
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
7.61B
8.04B
9.42B
10.03B
Cost of goods sold
-
-
-
778.00M
Cost of revenue
-
-
-
778.00M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.82B
5.16B
5.68B
6.39B
Operating expense
6.27B
6.87B
8.22B
7.99B
Total operating expenses
6.27B
6.87B
8.22B
8.77B
Operating income
1.34B
1.17B
1.20B
1.26B
Other non operating income
221.00M
197.00M
194.00M
-620.00M
EBT including unusual items
1.52B
1.33B
1.35B
1.05B
EBT excluding unusual items
1.52B
1.33B
1.35B
944.00M
Income tax expense
357.00M
310.00M
318.00M
254.00M
Effective tax rate
23.47%
23.29%
23.61%
24.17%
Other operating expenses
1.24B
1.48B
2.15B
1.18B
Net income
1.16B
1.02B
1.03B
797.00M
Net profit margin
15.30%
12.70%
10.92%
7.94%
Earnings per share
4.82
4.23
4.26
3.94
Interest and investment income
-
-
-
363.00M
Interest expense
-37.00M
-38.00M
-46.00M
-39.00M
Net interest expenses
-37.00M
-38.00M
-46.00M
324.00M
Depreciation and amortization charges
216.00M
234.00M
396.00M
418.00M
EBITDA
1.47B
1.40B
1.33B
1.49B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer